VX-407

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VX-407, covering 2025-07-14 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW) [Phase 2]